Public Profile

King Pharmaceuticals LLC

King Pharmaceuticals LLC, headquartered in the United States, is a prominent player in the pharmaceutical industry, specialising in the development and marketing of innovative therapeutic solutions. Founded in 1994, the company has achieved significant milestones, including strategic acquisitions that have expanded its portfolio and market reach. With a focus on pain management and other critical therapeutic areas, King Pharmaceuticals offers a range of unique products that address unmet medical needs. Their commitment to quality and innovation has positioned them as a trusted name in the healthcare sector. Notably, the company has garnered recognition for its contributions to patient care, solidifying its status as a leader in the pharmaceutical landscape.

DitchCarbon Score

How does King Pharmaceuticals LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

45

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

King Pharmaceuticals LLC's score of 45 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

King Pharmaceuticals LLC's reported carbon emissions

King Pharmaceuticals LLC, headquartered in the US, currently does not have publicly available data regarding its carbon emissions or specific climate commitments. Without emissions data, it is challenging to assess their environmental impact or track any reduction initiatives. The absence of documented reduction targets or commitments to frameworks such as the Science Based Targets Initiative (SBTi) suggests that the company may not have formalised its climate strategy at this time. As the pharmaceutical industry increasingly prioritises sustainability, it will be important for King Pharmaceuticals to establish clear climate commitments and emissions reduction goals to align with industry standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. King Pharmaceuticals LLC's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for King Pharmaceuticals LLC is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

King Pharmaceuticals LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Vanda Pharmaceuticals Inc.

US
Health and social work services (85)
Updated 2 days ago

Procter And Gamble

US
Chemicals nec
Updated 2 days ago

Pharmanutra

IT
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Meda Pharmaceuticals Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago
DitchCarbon Score

Transaction Holdings

US
Updated 3 months ago
DitchCarbon Score

Zyla Life Sciences

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers